CRDL

Cardiol Therapeutics Inc.

Contracts

Total Value

Stock Metrics

0.0%

Short % Float

2.3d to cover · Low squeeze

25.9%

Inst % Float

10 holders · 2026-06-30

MMCAP Internationa

Top Holder

13.3% of float

35/100

Dilution Score

Medium

Verified regulatory filings & proprietary analysis.

Dilution Risk

35/100

MEDIUM

Inst: 25.92% · Top: MMCAP International, Inc. SPC

Biotech Analytics

Cardiovascular Rare

19.13

Biotech Grade: F

Insider Buying0

Publications100

Dilution Risk35

Clinical Trials25

Short Interest10